Ge, Junwei
Jiang, Hongwei
Chen, Junjun
Chen, Xuemin
Zhang, Yue
Shi, Liangrong
Zheng, Xiao
Jiang, Jingting
Chen, Lujun
Funding for this research was provided by:
the National Natural Science Foundation of China (82172689, 82473269, 82373219)
the Provincial-level Talent Program for National Center of Technology Innovation for Biopharmaceuticals (NCTIB2024JS0101)
National Key Research and Development Program of China (BE2022721)
the Leading Talent of Changzhou "The 14th Five-Year Plan" High-Level Health Talents Training Project (2024CZLJ009)
Changzhou Medical Center of Nanjing Medical University (CZKYCMCC202301)
Article History
Received: 6 September 2024
Accepted: 2 January 2025
First Online: 21 January 2025
Declarations
:
: The present study involving in human participants was approved by the Clinical Research Ethics Committee at Outdo Biotech (Shanghai, China, SHYJS-CP-1701002). The studies adhered to local laws and institutional guidelines. Prior to participation, all participants provided written informed consent. The study also adhered to the Declaration of Helsinki.
: Not applicable.
: The authors are accountable for all aspects of the work, including ensuring that any questions related to the accuracy or integrity of any part of the work have been appropriately investigated and resolved.
: The authors declare no competing interests.